OCUPHIRE PHARMA INC. - COMMON STOCK
1.2900
27-9月-24 15:59:54
15 分の遅延
株式
-0.0100
-0.77%
本日の幅
1.2502 - 1.3050
ISIN
N/A
ソース
NASDAQ
-
Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol New Drug Application from FDA
12 9 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
08 9 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at The H.C. Wainwright 24th Annual Global Investment Conference
06 9 2022 09:00:01 提供 Nasdaq GlobeNewswire
-
12 8 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Upcoming Presentations at Two Conferences in August
08 8 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
03 8 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
07 7 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
29 6 2022 09:00:37 提供 Nasdaq GlobeNewswire
-
08 6 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
19 5 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2022 and Provides Corporate Update
13 5 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
11 5 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Ocuphire Announces Upcoming Clinical Presentations at ARVO 2022 Medical Meeting and MODLive! 2022
26 4 2022 09:00:02 提供 Nasdaq GlobeNewswire
-
19 4 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA
06 4 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
29 3 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
24 3 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
16 3 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Oppenheimer Annual Healthcare Conference
10 3 2022 09:27:42 提供 Nasdaq GlobeNewswire